Center for Definitive and Curative Medicine
Our primary prioritization is based on unmet medical need, rationale, strength of the research data and alignment with strategic priorities of the Center. We believe that the medical needs take priority over market size of the therapy’s indication and therapy's potential financial upside. To achieve these goals, the CDCM focuses on a vertically-integrated, interconnected program of aggressive pre-clinical prioritization, cell product manufacturing facility, clinical trial office, and patient bed
Basic Information
- Category: organization
- Website: https://med.stanford.edu/cdcm
Evidence and Sources
Citation Guidance
Explore organization profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Center for Definitive and Curative Medicine.
- Canonical profile: https://brandsource.ai/brands/center-for-definitive-and-curative-medicine
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/center-for-definitive-and-curative-medicine/json-ld
- Citation profile API: https://brandsource.ai/api/brands/center-for-definitive-and-curative-medicine/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (78/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Our primary prioritization is based on unmet medical need, rationale, strength of the research data and alignment with strategic priorities of the Center. We believe that the medical needs take priority over market size of the therapy’s indication and therapy's potential financial upside. To achieve these goals, the CDCM focuses on a vertically-integrated, interconnected program of aggressive pre-clinical prioritization, cell product manufacturing facility, clinical trial office, and patient bed
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.